Application 091226
- Type
- ANDA
- Sponsor
- MYLAN PHARMS INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | TABLET;ORAL | EQ 10MG BASE | No | No |
| 002 | ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | TABLET;ORAL | EQ 20MG BASE | No | No |
| 003 | ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | TABLET;ORAL | EQ 40MG BASE | No | No |
| 004 | ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | TABLET;ORAL | EQ 80MG BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A091226-001 | ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | AB | 2012-05-29 | |
| A091226-002 | ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | AB | 2012-05-29 | |
| A091226-003 | ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | AB | 2012-05-29 | |
| A091226-004 | ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | AB | 2012-05-29 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A091226-001 | AB |
| A091226-002 | AB |
| A091226-003 | AB |
| A091226-004 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A091226-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | AB | 2012-05-29 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A091226-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | AB | 2012-05-29 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A091226-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | AB | 2012-05-29 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A091226-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | AB | 2012-05-29 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091226-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | AB | 2012-05-29 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091226-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | AB | 2012-05-29 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091226-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | AB | 2012-05-29 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091226-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | AB | 2012-05-29 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A091226-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | AB | 2012-05-29 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A091226-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | AB | 2012-05-29 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A091226-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | AB | 2012-05-29 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A091226-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | AB | 2012-05-29 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091226-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | AB | 2012-05-29 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091226-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | AB | 2012-05-29 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091226-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | AB | 2012-05-29 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091226-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | AB | 2012-05-29 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091226-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | AB | 2012-05-29 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091226-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | AB | 2012-05-29 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091226-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | AB | 2012-05-29 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091226-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | AB | 2012-05-29 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091226-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | AB | 2012-05-29 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091226-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | AB | 2012-05-29 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091226-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | AB | 2012-05-29 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091226-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | AB | 2012-05-29 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091226-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | AB | 2012-05-29 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091226-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | AB | 2012-05-29 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091226-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | AB | 2012-05-29 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091226-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | AB | 2012-05-29 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091226-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | AB | 2012-05-29 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091226-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | AB | 2012-05-29 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091226-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | AB | 2012-05-29 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091226-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | AB | 2012-05-29 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091226-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | AB | 2012-05-29 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091226-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | AB | 2012-05-29 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091226-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | AB | 2012-05-29 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091226-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | AB | 2012-05-29 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A091226-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | AB | 2012-05-29 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A091226-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | AB | 2012-05-29 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A091226-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | AB | 2012-05-29 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A091226-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | AB | 2012-05-29 | d06236e962d9… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A091226-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A091226-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A091226-003 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A091226-004 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091226-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091226-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091226-003 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091226-004 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A091226-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A091226-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A091226-003 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A091226-004 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091226-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091226-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091226-003 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091226-004 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091226-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091226-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091226-003 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091226-004 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091226-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091226-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091226-003 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091226-004 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091226-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091226-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091226-003 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091226-004 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091226-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091226-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091226-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091226-004 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091226-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091226-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091226-003 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091226-004 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A091226-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A091226-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A091226-003 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A091226-004 | AB | 1 | d06236e962d9… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Atorvastatin Calcium | ATORVASTATIN CALCIUM | Cardinal Health 107, LLC | fbd1c5da-67fb-4412-acb5-4d4c74a43654 | 2026-07-24 | Warnings, Adverse reactions | 091226 ANDA091226 |
| Atorvastatin Calcium | ATORVASTATIN CALCIUM | Cardinal Health 107, LLC | aee307d6-b3fa-424f-8656-1f30ff413e95 | 2026-05-01 | Warnings, Adverse reactions | 091226 ANDA091226 55154-4384 |
| Atorvastatin Calcium | ATORVASTATIN CALCIUM | Safecor Health, LLC | 6d552a6f-d7a2-4dba-8e71-2b97b4ee2faf | 2026-02-24 | Warnings, Adverse reactions | 091226 ANDA091226 |
| Atorvastatin Calcium | ATORVASTATIN CALCIUM | Mylan Institutional Inc. | 7c1083b9-7a20-475d-ba12-4f5d0b53e601 | 2025-07-18 | Warnings, Adverse reactions | 091226 ANDA091226 51079-208 51079-209 51079-210 51079-211 |
| Atorvastatin Calcium | ATORVASTATIN CALCIUM | Mylan Pharmaceuticals Inc. | d0a0feb6-84f0-4693-a11f-eb4f7ae0a87d | 2024-04-12 | Warnings, Adverse reactions | 091226 ANDA091226 0378-3950 0378-3953 0378-3952 0378-3951 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0378-3950 | Atorvastatin Calcium | atorvastatin calcium | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-3950 | Atorvastatin Calcium | atorvastatin calcium | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-3950 | Atorvastatin Calcium | atorvastatin calcium | Mylan Pharmaceuticals Inc | ANDA | Current |
| 0378-3950 | Atorvastatin Calcium | atorvastatin calcium | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-3950 | Atorvastatin Calcium | atorvastatin calcium | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-3950 | Atorvastatin Calcium | atorvastatin calcium | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-3950 | Atorvastatin Calcium | atorvastatin calcium | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-3950 | Atorvastatin Calcium | atorvastatin calcium | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-3951 | Atorvastatin Calcium | atorvastatin calcium | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-3951 | Atorvastatin Calcium | atorvastatin calcium | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-3951 | Atorvastatin Calcium | atorvastatin calcium | Mylan Pharmaceuticals Inc | ANDA | Current |
| 0378-3951 | Atorvastatin Calcium | atorvastatin calcium | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-3951 | Atorvastatin Calcium | atorvastatin calcium | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-3951 | Atorvastatin Calcium | atorvastatin calcium | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-3951 | Atorvastatin Calcium | atorvastatin calcium | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-3951 | Atorvastatin Calcium | atorvastatin calcium | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-3952 | Atorvastatin Calcium | atorvastatin calcium | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-3952 | Atorvastatin Calcium | atorvastatin calcium | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-3952 | Atorvastatin Calcium | atorvastatin calcium | Mylan Pharmaceuticals Inc | ANDA | Current |
| 0378-3952 | Atorvastatin Calcium | atorvastatin calcium | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-3952 | Atorvastatin Calcium | atorvastatin calcium | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-3952 | Atorvastatin Calcium | atorvastatin calcium | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-3952 | Atorvastatin Calcium | atorvastatin calcium | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-3952 | Atorvastatin Calcium | atorvastatin calcium | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-3953 | Atorvastatin Calcium | atorvastatin calcium | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-3953 | Atorvastatin Calcium | atorvastatin calcium | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-3953 | Atorvastatin Calcium | atorvastatin calcium | Mylan Pharmaceuticals Inc | ANDA | Current |
| 0378-3953 | Atorvastatin Calcium | atorvastatin calcium | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-3953 | Atorvastatin Calcium | atorvastatin calcium | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-3953 | Atorvastatin Calcium | atorvastatin calcium | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-3953 | Atorvastatin Calcium | atorvastatin calcium | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-3953 | Atorvastatin Calcium | atorvastatin calcium | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 43353-181 | Atorvastatin Calcium | atorvastatin calcium | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 43353-181 | Atorvastatin Calcium | atorvastatin calcium | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 43353-181 | Atorvastatin Calcium | atorvastatin calcium | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 43353-182 | Atorvastatin Calcium | atorvastatin calcium | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 43353-182 | Atorvastatin Calcium | atorvastatin calcium | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 43353-182 | Atorvastatin Calcium | atorvastatin calcium | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 43353-184 | Atorvastatin Calcium | atorvastatin calcium | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 43353-184 | Atorvastatin Calcium | atorvastatin calcium | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 43353-184 | Atorvastatin Calcium | atorvastatin calcium | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 51079-208 | Atorvastatin Calcium | atorvastatin calcium | Mylan Institutional Inc. | ANDA | Current |
| 51079-208 | Atorvastatin Calcium | atorvastatin calcium | Mylan Institutional Inc. | ANDA | Current |
| 51079-208 | Atorvastatin Calcium | atorvastatin calcium | Mylan Institutional Inc. | ANDA | Current |
| 51079-208 | Atorvastatin Calcium | atorvastatin calcium | Mylan Institutional Inc. | ANDA | Current |
| 51079-208 | Atorvastatin Calcium | atorvastatin calcium | Mylan Institutional Inc. | ANDA | Current |
| 51079-208 | Atorvastatin Calcium | atorvastatin calcium | Mylan Institutional Inc. | ANDA | Current |
| 51079-209 | Atorvastatin Calcium | atorvastatin calcium | Mylan Institutional Inc. | ANDA | Current |
| 51079-209 | Atorvastatin Calcium | atorvastatin calcium | Mylan Institutional Inc. | ANDA | Current |
| 51079-209 | Atorvastatin Calcium | atorvastatin calcium | Mylan Institutional Inc. | ANDA | Current |
| 51079-209 | Atorvastatin Calcium | atorvastatin calcium | Mylan Institutional Inc. | ANDA | Current |
| 51079-209 | Atorvastatin Calcium | atorvastatin calcium | Mylan Institutional Inc. | ANDA | Current |
| 51079-209 | Atorvastatin Calcium | atorvastatin calcium | Mylan Institutional Inc. | ANDA | Current |
| 51079-210 | Atorvastatin Calcium | atorvastatin calcium | Mylan Institutional Inc. | ANDA | Current |
| 51079-210 | Atorvastatin Calcium | atorvastatin calcium | Mylan Institutional Inc. | ANDA | Current |
| 51079-210 | Atorvastatin Calcium | atorvastatin calcium | Mylan Institutional Inc. | ANDA | Current |
| 51079-210 | Atorvastatin Calcium | atorvastatin calcium | Mylan Institutional Inc. | ANDA | Current |
| 51079-210 | Atorvastatin Calcium | atorvastatin calcium | Mylan Institutional Inc. | ANDA | Current |
| 51079-210 | Atorvastatin Calcium | atorvastatin calcium | Mylan Institutional Inc. | ANDA | Current |
| 51079-211 | Atorvastatin Calcium | atorvastatin calcium | Mylan Institutional Inc. | ANDA | Current |
| 51079-211 | Atorvastatin Calcium | atorvastatin calcium | Mylan Institutional Inc. | ANDA | Current |
| 51079-211 | Atorvastatin Calcium | atorvastatin calcium | Mylan Institutional Inc. | ANDA | Current |
| 51079-211 | Atorvastatin Calcium | atorvastatin calcium | Mylan Institutional Inc. | ANDA | Current |
| 51079-211 | Atorvastatin Calcium | atorvastatin calcium | Mylan Institutional Inc. | ANDA | Current |
| 51079-211 | Atorvastatin Calcium | atorvastatin calcium | Mylan Institutional Inc. | ANDA | Current |
| 55154-4384 | Atorvastatin Calcium | atorvastatin calcium | Cardinal Health | ANDA | Current |
| 55154-4384 | Atorvastatin Calcium | atorvastatin calcium | Cardinal Health | ANDA | Current |
| 55154-4384 | Atorvastatin Calcium | atorvastatin calcium | Cardinal Health 107, LLC | ANDA | Current |
| 55154-4384 | Atorvastatin Calcium | atorvastatin calcium | Cardinal Health | ANDA | Current |
| 70518-0198 | Atorvastatin Calcium | atorvastatin calcium | REMEDYREPACK INC. | ANDA | Current |
| 70518-0462 | Atorvastatin Calcium | atorvastatin calcium | REMEDYREPACK INC. | ANDA | Current |
| 70518-0567 | Atorvastatin Calcium | atorvastatin calcium | REMEDYREPACK INC. | ANDA | Current |
| 70518-0567 | Atorvastatin Calcium | atorvastatin calcium | REMEDYREPACK INC. | ANDA | Current |